The BRCA2 gene plays an important role in repairing damaged DNA, which supports healthy cell growth. If it does not work properly, cells can collect extra DNA changes, which can raise the chance of breast, ovarian, prostate, pancreatic, and some other cancers. Many variants are harmless, while certain inherited variants in the BRCA2 gene are linked to hereditary cancer risk. Public awareness of BRCA genes rose after Angelina Jolie shared her BRCA1 result and preventive surgery, which also brought more attention to the BRCA2 gene.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for building proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
BRCA2Gene function
What if the gene works
The BRCA2 gene helps cells repair damaged DNA, especially breaks affecting both DNA strands. This helps keep genetic information stable and supports healthy cell growth.
Risk
What if the gene does not work
Variants in the BRCA2 gene can weaken DNA repair. Milder to more severe variants may change how high cancer risk is, especially for breast, ovarian, prostate, pancreatic, and male breast cancers. Rarely, two harmful variants cause Fanconi anemia.
Treatment
What does that mean for your treatment
A pathogenic variant in the BRCA2 gene can guide cancer treatment because tumors with this change may respond to PARP inhibitors such as olaparib, talazoparib, niraparib, and rucaparib in guideline defined settings. In some cancers, platinum based chemotherapy may also be considered because BRCA2 related tumors can be more sensitive to this type of treatment.
Conditions associated with BRCA2
Gene function
What if the gene works
Every day, your cells need to copy and protect their DNA as they grow and divide. The BRCA2 gene helps manage this work so cells can keep their genetic instructions accurate. Its protein is especially important when cells need to repair damaged DNA and copy DNA safely.
The BRCA2 gene helps your cells fix certain DNA breaks by using an intact matching DNA section as a guide. It places RAD51, a repair protein, onto DNA so the broken area can be rebuilt more accurately.
During cell division, BRCA2 helps protect DNA while it is being copied. This supports a smoother copying process and helps the cell avoid losing its place in the genetic code.
By supporting accurate repair and careful DNA copying, BRCA2 helps cells keep their genetic instructions stable over time. This steady upkeep is a key part of normal everyday cell function.
What is a variant?
A genetic variant is a slight alteration in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants in the BRCA2 gene affect DNA repair explains why some changes matter more than others. Some variants shorten the BRCA2 protein, make it unstable, or weaken its contact with repair partners, so damaged DNA is fixed less accurately. Milder variants may leave part of this activity, while more severe loss of function variants can remove most of it. In people with pathogenic variants in the BRCA2 gene, that often relates to cancer risk and sometimes earlier onset.
How variants are linked to conditions
For many families, BRCA2 gene and cancer risk come up together because pathogenic variants in the BRCA2 gene cause hereditary breast and ovarian cancer syndrome. These variants are linked to higher risks of breast, ovarian, male breast, prostate, and pancreatic cancers, and some are also associated with melanoma. Carrying a BRCA2 variant does not mean cancer is certain, but it can strongly raise lifetime risk.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not have a direct impact on health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful BRCA2 change, cancer risk is driven mainly by the variant itself, and it also varies with age, sex, and family history. Some studies suggest factors like body weight, alcohol, and smoking may affect overall cancer risk, but they do not remove the inherited risk. Regular screening and risk-reducing care can still make a major difference.
Inheritance of BRCA2 variants
The inheritance pattern for BRCA2-related conditions depends on the specific condition and how many changed copies of the BRCA2 gene are present. For hereditary breast, ovarian, prostate, pancreatic, and some other cancer risks, a harmful variant in one copy of the BRCA2 gene is usually inherited in an autosomal dominant way, so each child has a 50% chance of inheriting it. In contrast, when a child inherits harmful variants in both copies of the BRCA2 gene, this can cause a rare childhood condition called Fanconi anemia, which follows an autosomal recessive pattern. This is the key point in how BRCA2 is inherited in families.
What does my BRCA2 result mean for my family?
For a cancer-related BRCA2 result, close relatives like parents, brothers, sisters, and children may also carry the same gene change, so it can matter for the wider family. BRCA2 can also be linked to a rarer childhood condition when a child inherits changed copies from both parents, so family meaning depends on the exact result and condition. Sharing the result with relatives can help them decide whether to learn more about their own chances.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the BRCA2 gene, genetic testing for BRCA2 variants uses DNA from a blood sample or saliva sample. A lab reads the gene's code and reports whether it finds a pathogenic variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider BRCA2 testing if you or close relatives have had breast, ovarian, prostate, or pancreatic cancer, especially at a young age or in several family members. Testing is also worth discussing if a relative has a known BRCA2 gene change or if there is male breast cancer in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, how strongly a medicine works, or how likely side effects are. This helps explain why the same treatment may work well for one person but less well for another. These differences are common and are one part of the bigger picture, along with age, kidney and liver function, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect how the body processes a drug or how strong its effects are. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the BRCA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed medication-response role for this gene, so general questions about medicines or side effects are best discussed with your doctor. If you are being treated for cancer, BRCA2 changes can sometimes help guide use of certain targeted treatments, especially PARP inhibitor medicines.
History
Across cultures and time periods, inherited patterns were noted in families with many cases of breast and ovarian cancer. In the 1990s, researchers narrowed this pattern to a region on chromosome 13, and in 1995 the BRCA2 gene was identified. This discovery followed the earlier finding of BRCA1 and helped confirm that some cancers can run in families because of inherited gene variants. From these first observations, research expanded steadily, showing that the BRCA2 gene also matters in some prostate, pancreatic, and male breast cancers. Its discovery became a milestone in cancer genetics and changed how doctors think about inherited cancer risk. Over time, this work also shaped genetic counseling, family testing, and prevention discussions in everyday care.